
Evotec SE (EVO) Stock Forecast & Price Target
Evotec SE (EVO) Analyst Ratings
Bulls say
Evotec has reported a notable increase in orders within its Discovery segment, which has risen by 70%, positioning the company for a revenue recovery projected for late 2024, particularly as this segment constitutes approximately 70% of the shared R&D revenues. In 2Q24, the company achieved total revenue of €182.1 million, reflecting a year-over-year growth of 7.0% compared to €170.3 million in the previous year, and anticipates significant growth in FY24 with double-digit revenue increases and mid-double-digit growth in adjusted EBITDA. The overall revenue for 2023 reached €781.4 million, marking a 4% year-over-year increase, with positive financial guidance indicating a strong outlook for continued expansion.
Bears say
Evotec reported a total revenue decline of 2.3% year-over-year for 1Q24, totaling €208.7 million, down from €213.6 million in the previous year. Additionally, the company's 2Q results showed a substantial 19% quarter-over-quarter decrease in revenue despite a 7% year-over-year increase, underlining a concerning volatility in revenue generation. Furthermore, Evotec's management retracted its prior mid-term targets for 2025 and provided lower-than-expected guidance for 2024, signaling potential challenges ahead in achieving sustainable growth and profitability.
This aggregate rating is based on analysts' research of Evotec SE and is not a guaranteed prediction by Public.com or investment advice.
Evotec SE (EVO) Analyst Forecast & Price Prediction
Start investing in Evotec SE (EVO)
Order type
Buy in
Order amount
Est. shares
0 shares